Federal health officials are accelerating efforts to bring cheaper biotech drugs to market, potentially transforming treatment access and creating new opportunities for Indian pharmaceutical companies.
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
In a volatile trading session, one FMCG stock under ₹500 surged 4% after the company approved a rights issue. Discover why analysts are bullish on this consumer goods player and what the rights issue means for investors.
Discover why this affordable small-cap stock surged 10% during India's market recovery. Get expert insights on the rally drivers and future prospects for budget-friendly investments.
Discover how this small-cap stock transformed from ₹1 to record highs with 20% upper circuit. Learn the secret behind its massive 2,100% rally and what's driving investor frenzy.
Mozilla Securities expert Vaishali Parekh reveals three promising stocks to buy today with specific entry prices and targets. Get expert technical analysis on Hindustan Aeronautics, JSW Energy, and Tata Motors DVR.
Discover why prominent investor Mukul Agrawal is betting big on a small-cap pharma company with massive growth potential. Get exclusive insights into his latest portfolio move and what it means for retail investors.
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?
Foreign institutional investors are aggressively increasing their stake in a remarkable penny stock that has delivered staggering 2,300% returns over five years. Discover why this multibagger is capturing smart money attention in Q2 FY26.
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
Indian pharmaceutical giant Cipla announces landmark deal with Eli Lilly to manufacture and distribute popular weight loss medications Mounjaro and Zepbound in India under different brand names.
Indian pharma giant Aurobindo Pharma establishes new subsidiary in Chile, marking strategic expansion across South American markets with focus on branded prescriptions and over-the-counter medicines.
A budget-friendly logistics stock trading below ₹50 has witnessed significant gains after the company shared crucial updates with stock exchanges. Discover why investors are rushing to buy this penny stock and what it means for your portfolio.
Discover why this small-cap stock is outperforming the market with a nearly 6% surge. Get expert insights on the rally and future prospects for savvy investors.
In a major pharmaceutical industry move, Torrent Pharmaceuticals receives Competition Commission of India approval to acquire controlling stake in JB Chemicals & Pharmaceuticals, marking significant consolidation in Indian pharma sector.
A significant legal triumph for India's pharmaceutical sector strengthens the position of generic drug makers against patent challenges. Explore how this ruling impacts affordable medicine production and India's role as the 'Pharmacy of the World'.
Danish pharma giant Novo Nordisk, the company behind diabetes & weight-loss blockbusters Ozempic and Wegovy, announces a major boardroom reshuffle. Get the inside scoop on the new faces and strategic direction.
Meet the trailblazing female entrepreneurs who built healthcare empires from scratch and are reshaping medical innovation worldwide. Discover their inspiring journeys to billions.
Delhi Police uncovers how Nigerian drug cartels are recruiting Indian students from pharma colleges, providing specialized training, and creating sophisticated dispatch systems to smuggle narcotics globally.
Expert analysis compares Zydus Lifesciences and Rubicon Research in the booming Indian pharmaceutical sector. Discover key financial metrics, growth drivers, and investment outlook for these promising stocks.
India's pharmaceutical sector gears up for Q2 FY25 with projected 5-7% revenue growth, navigating US pricing pressures and domestic GST reductions while maintaining stable profitability.
Multibagger stock Colab Platforms continues its unprecedented rally, hitting upper circuit for 87 consecutive sessions. Discover what's driving this phenomenal growth before Muhurat trading 2025.
Discover how this affordable small-cap stock delivered impressive Q2 growth with soaring profits and revenue. Is it the next multibagger in your portfolio?
Discover the incredible journey of a circuit-to-circuit stock that created history with 90 straight upper circuits, delivering massive returns to investors ahead of Muhurat Trading 2025.
In a major breakthrough, Narcotics Control Bureau uncovers sophisticated drug manufacturing unit in Madhya Pradesh's Ratlam district. Highly educated pharma graduates among those arrested in interstate narcotics operation.
India mandates safety QR codes on all essential medicines in public healthcare, transforming drug safety and combating counterfeit drugs with digital innovation.
Madhya Pradesh's Special Investigation Team gears up for significant arrests in the Sresan Pharma cough syrup case that claimed young lives. Exclusive details on the expanding investigation.
In a landmark judgment, India's Supreme Court allows Natco Pharma to produce affordable generic version of Roche's expensive spinal muscular atrophy treatment, making life-saving therapy accessible to thousands.